3-(2-Chloro-thiazol-5-ylMethoxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C14H21ClN2O3S, MW: 332.85
- $456 - $499.48
- Product name: 3-(2-Chloro-thiazol-5-ylMethoxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C14H21ClN2O3S, MW: 332.85
- CAS: 939986-94-4
- MF: C14H21ClN2O3S
- MW: 332.85
- EINECS:
- MDL Number:MFCD09607887
- Synonyms:3-[(2-Chloro-5-thiazolyl)methoxy]-1-piperidinecarboxylic acid tert-butyl ester;3-(2-Chloro-thiazol-5-ylMethoxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C14H21ClN2O3S, MW: 332.85;1-Piperidinecarboxylic acid, 3-[(2-chloro-5-thiazolyl)methoxy]-, 1,1-dimethylethyl ester
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0295655
- Product descriptionTERT-BUTYL-3-(2-CHLORO-THIAZOL-5-YLMETHOXY)-PIPERIDINE-1-CARBOXYLATE 95.00%
- Packaging5MG
- Price$499.48
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM181214
- Product descriptiontert-butyl3-((2-chlorothiazol-5-yl)methoxy)piperidine-1-carboxylate 95%
- Packaging1g
- Price$456
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11008225
- Product descriptiontert-Butyl3-((2-chlorothiazol-5-yl)methoxy)piperidine-1-carboxylate 95+%
- Packaging1g
- Price$482
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0295655 | TERT-BUTYL-3-(2-CHLORO-THIAZOL-5-YLMETHOXY)-PIPERIDINE-1-CARBOXYLATE 95.00% | 5MG | $499.48 | 2021-12-16 | Buy |
Chemenu | CM181214 | tert-butyl3-((2-chlorothiazol-5-yl)methoxy)piperidine-1-carboxylate 95% | 1g | $456 | 2021-12-16 | Buy |
Crysdot | CD11008225 | tert-Butyl3-((2-chlorothiazol-5-yl)methoxy)piperidine-1-carboxylate 95+% | 1g | $482 | 2021-12-16 | Buy |
Properties
Density :1.26
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|